Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chinese Journal of Applied Physiology ; (6): 72-76, 2010.
Artigo em Chinês | WPRIM | ID: wpr-356213

RESUMO

<p><b>OBJECTIVE</b>To observe the therapeutic time window of L-serine against focal cerebral ischemia/reperfusion injury in rats, and related mechanisms.</p><p><b>METHODS</b>Sprague-Dawley rats were randomly divided into six groups (n=6), sham-operation group, vehicle group, 3, 6, 12 and 24 h treatment group of L-serine. Focal cerebral ischemia was induced with the method of middle cerebral artery occlusion (MCAO) in rats, and reperfusion was emerged by removing the thread 2 h later. The treatment of L-serine (200 mg/kg ip) was begun at 3, 6, 12 and 24 h after MCAO respectively, and subsequently repeated once 12 h. The vehicle group was intraperitoneally injected with isodose normal saline. The neurological behavior score and cerebral infarction volume was measured 48 h after reperfusion. In addition, the contents of malondialdehyde (MDA), activity of superoxide dismetase (SOD), the levels of inflammatory cytokines (TNF-alpha, IL-6) and ultrastructure of neuron in brain tissue were investigated.</p><p><b>RESULTS</b>Compared with the vehicle group, treatments with L-serine both 3 and 6 h after MCAO decreased the neurology deficit score and infarct volume. Only neurology deficit score had been reduced 12 h after MCAO, while no neuropmrotective effects had been observed during 24 h. Furthermore, L-serine elevated the content of SOD, decreased the level of MDA, TNF-alpha and IL-6 in ischemic brain tissue, and alleviated the injury of the neuronal ultrastructure.</p><p><b>CONCLUSION</b>L-serine exerted a time-dependent neuroprotective effect on the brain after MCAO in rat. This effect might be possibly mediated through following mechanisms: lessening oxidative stress and reducing the release of inflammatory cytokines.</p>


Assuntos
Animais , Masculino , Ratos , Isquemia Encefálica , Tratamento Farmacológico , Patologia , Interleucina-6 , Metabolismo , Fármacos Neuroprotetores , Usos Terapêuticos , Estresse Oxidativo , Ratos Sprague-Dawley , Traumatismo por Reperfusão , Serina , Usos Terapêuticos , Superóxido Dismutase , Metabolismo , Fatores de Tempo , Fator de Necrose Tumoral alfa , Metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA